Clinical Trial Update: Phase II Dutasteride in Combination With CAB vs CAB in SDC [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating dutasteride in combination with a CAB regimen versus CAB alone in salivary duct carcinoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Salivary Duct Carcinoma

Drugs mentioned

• CAB regimen (cyclophosphamide, doxorubicin, bleomycin)
• DUTASTERIDE (Dutasteride)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Salivary Duct Carcinoma | Phase 2 | Status: RECRUITING